Systematic Review and UK‐Based Study of <i>PARK2 (parkin), PINK1, PARK7 (DJ‐1)</i> and <i>LRRK2</i> in early‐onset Parkinson's disease
Laura L. Kilarski(University of Bonn), Huw R. Morris(University College London), Carl E Clarke(German Center for Neurodegenerative Diseases), David J. Burn(Ollscoil na Gaillimhe – University of Galway), Marie-Hélène Marion(St George's Hospital), Patrick F. Chinnery(Wellcome Centre for Mitochondrial Research), Justin Pearson(Cardiff University), Duleeka Knipe(University of Peradeniya), Yoav Ben‐Shlomo(University of Bristol), Alistair Lewthwaite(University Hospitals Birmingham NHS Foundation Trust), David Nicholl(Sandwell & West Birmingham Hospitals NHS Trust), Nicholas Wood(National Hospital for Neurology and Neurosurgery), Elisa Majounie(Illumina (United States)), Nigel Williams(NHS England), Stephen Sawcer(University of Cambridge), Mirdhu Wickremaratchi(Worthing Hospital), Roger A. Barker(University of Cambridge), Karen Morrison(University Hospitals Birmingham NHS Foundation Trust), Jonathan Evans(University of Liverpool), Anjum Misbahuddin(Barking, Havering And Redbridge University Hospitals NHS Trust), Victoria Newsway(Cardiff University), Caroline H. Williams‐Gray(University of Cambridge)
Cited by 170
Related Papers
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|Nature|2011|2.8k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Suicide risk and prevention during the COVID-19 pandemic
|The Lancet Psychiatry|2020|1.6k